TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33844165

Group type: EXPERIMENTAL
Intervention: Total thyroid ablation (TTA) with 15 mCi of radioiodine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Thyroidectomy (Tx) alone
Number of subjects: 32
Study: 33017050

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (<25 nmol/L)
Number of subjects: 351320

Group type: EXPERIMENTAL
Intervention: Insufficient vitamin D levels (25–50 nmol/L)
Number of subjects: 351320

Group type: EXPERIMENTAL
Intervention: Genetically instrumented vitamin D increase
Number of subjects: 351320
Study: 35492015

Group type: EXPERIMENTAL
Intervention: Meat imagery
Number of subjects: 514

Group type: COMPARATOR
Intervention: Control (no food imagery)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Non-meat imagery
Number of subjects: 514
Study: 32138624

Group type: EXPERIMENTAL
Intervention: Human urinary kallidinogenase (HUK)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35640630

Group type: EXPERIMENTAL
Intervention: Acute exposure to hypobaric hypoxia (HH) at 5000 m asl
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Simulated cardiopulmonary resuscitation (SCR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS) performance
Number of subjects: 48
Study: 32803551

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy with cetuximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postoperative adjuvant chemotherapy
Number of subjects: 0
Study: 33971940

Group type: EXPERIMENTAL
Intervention: Naoxintong (NXT) capsule (3 pills, 3 times daily for 12 weeks)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Naoxintong (NXT) capsule
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo (3 pills, 3 times daily for 12 weeks)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study: 32814493

Group type: EXPERIMENTAL
Intervention: Laxatives and abdominal massage (Group I)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Laxatives, acupoint pressure therapy (APT), and abdominal massage (Group II)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Laxatives only (Control Group)
Number of subjects: 90
Study: 34875363

Group type: EXPERIMENTAL
Intervention: Mirror therapy
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sensory relearning
Number of subjects: 6
Study: 33672691

Group type: EXPERIMENTAL
Intervention: Telerehabilitation Program (TP) based on aerobic exercise, 15 weeks, 2 sessions per week
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 35731653

Group type: EXPERIMENTAL
Intervention: Bivalent prefusion F (RSVpreF) vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33268475

Group type: EXPERIMENTAL
Intervention: Advance care planning (ACP) intervention in general practice
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 38
Study: 37914510

Group type: EXPERIMENTAL
Intervention: Radiofrequency renal denervation (RDN)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 337
Study: 33332699

Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg
Number of subjects: 1518

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1518
Study: 32467339

Group type: EXPERIMENTAL
Intervention: Allergen alone exposure
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) and allergen coexposure
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Particle-depleted diesel exhaust (PDDE) and allergen coexposure
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 14
Study: 35072855

Group type: EXPERIMENTAL
Intervention: SITA Faster strategy (SFR)
Number of subjects: 59

Group type: COMPARATOR
Intervention: SITA Standard (SS)
Number of subjects: 59
Study: 33730032

Group type: EXPERIMENTAL
Intervention: High THC (approximately 12% THC and < 0.05% CBD)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High CBD (11% CBD and 0.50% THC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: THC+CBD (approximately 7.9% THC and 8.1% CBD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (< 0.03% THC and < 0.01% CBD)
Number of subjects: 80
Study: 32639468

Group type: EXPERIMENTAL
Intervention: Ambrisentan (2.5 mg in suspension, daily for 3 days)
Number of subjects: 16
Study: 37365489

Group type: EXPERIMENTAL
Intervention: New technique of intra-cesarean post placental introducer withdrawal IUD insertion (Copper T380)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Conventional manual method for IUD insertion (Copper T380)
Number of subjects: 840
Study: 34066577

Group type: EXPERIMENTAL
Intervention: Multi-nutrient fortified dairy-based drink (200 mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-nutrient fortified dairy-based drink (400 mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-nutrient fortified dairy-based drink (600 mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-nutrient fortified dairy-based drink (all dosages)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-nutrient fortified dairy-based drink
Number of subjects: 0
Study: 32911319

Group type: EXPERIMENTAL
Intervention: OraquickⓇ HCV-Ab screening
Number of subjects: 78

Group type: COMPARATOR
Intervention: Venipuncture HCV-Ab screening
Number of subjects: 78
Study: 36200642

Group type: EXPERIMENTAL
Intervention: Reduced-dose PTCy/ATG (40 mg/kg/d on days 3 and 4 for PTCy; 2.5 mg/kg on day 8 for ATG)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard-dose ATG (10 mg/kg)
Number of subjects: 122
Study: 33577862

Group type: EXPERIMENTAL
Intervention: TTM-based intervention
Number of subjects: 3414

Group type: COMPARATOR
Intervention: Usual care (Control Group)
Number of subjects: 3414
Study: 34536050

Group type: EXPERIMENTAL
Intervention: Exercise group (EXG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual care group (UCG)
Number of subjects: 39
Study: 33242631

Group type: EXPERIMENTAL
Intervention: Linear measurements of trochlear morphology
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Angular measurements (sulcus angle, medial trochlea slope, trochlea facet asymmetry)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Measurements in PFI group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Measurements in non-PFI group
Number of subjects: 66
Study: 36227597

Group type: EXPERIMENTAL
Intervention: Real Cost health harms group
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Real Cost addiction group
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Real Cost groups (combined)
Number of subjects: 1514

Group type: COMPARATOR
Intervention: Control group (investigator-created neutral videos about vaping)
Number of subjects: 1514
Study: 33640388

Group type: EXPERIMENTAL
Intervention: Moderate/severe vessel tortuosity
Number of subjects: 6951
Study: 32945647

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (non-responders)
Number of subjects: 44
Study: 35482448

Group type: EXPERIMENTAL
Intervention: Gracilis tendon graft with 2 tunnels (GT-2)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Gracilis tendon graft with 1 tunnel (GT-1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Semitendinosus tendon graft with 2 tunnels (ST-2)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Semitendinosus tendon graft with 1 tunnel (ST-1)
Number of subjects: 24
Study: 32296931

Group type: EXPERIMENTAL
Intervention: Hesperidin (1 g/day)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g/day)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Combination of flaxseed and hesperidin (30 g flaxseed and 1 g hesperidin)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (no supplement)
Number of subjects: 98
Study: 36283241

Group type: EXPERIMENTAL
Intervention: Vitamin C and Vitamin E supplementation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 33191781

Group type: EXPERIMENTAL
Intervention: DOAC
Number of subjects: 151

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 151
Study: 32794397

Group type: EXPERIMENTAL
Intervention: Filtek Bulk Fill high viscosity bulk‐fill resin
Number of subjects: 116

Group type: COMPARATOR
Intervention: Filtek Z350 XT nanoparticulate resin
Number of subjects: 116
Study: 34110641

Group type: EXPERIMENTAL
Intervention: Surgical treatment for chronic rhinosinusitis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 24
Study: 33254288

Group type: EXPERIMENTAL
Intervention: 3D U-net neural network
Number of subjects: 31
Study: 33586013

Group type: EXPERIMENTAL
Intervention: MRSA isolates from newly diagnosed HIV-infected adults
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: MRSA isolates
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Erythromycin-resistant MRSA isolates
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin-resistant MRSA isolates
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: All MRSA isolates
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: ST8 MRSA clones from Tanzania
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Carriage of ST8 MRSA
Number of subjects: 537
Study: 32246504

Group type: EXPERIMENTAL
Intervention: Deep learning algorithm trained on H&E stained images
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Deep learning algorithm trained on Papanicolaou stained images
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Deep learning algorithm trained on Diff-Quik® stained images
Number of subjects: 40
Study: 35779544

Group type: EXPERIMENTAL
Intervention: Comprehensive smoke-free legislation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (72 middle-income countries without legislation)
Number of subjects: 106
Study: 33587782

Group type: EXPERIMENTAL
Intervention: placebo‐TENS (inert electrical stimulation applied over the hand)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: placebo‐tDCS (sham transcranial direct current stimulation delivered to the supraorbital area)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 90
Study: 33306936

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 60
Study: 35618550

Group type: EXPERIMENTAL
Intervention: Nurse-administered telephone program
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Web-based interactive tool
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Nurse-administered telephone program (high dose >12 encounters)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Web-based interactive tool (high dose >1 web encounter)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Post-MI education-only group
Number of subjects: 415
Study: 33752423

Group type: EXPERIMENTAL
Intervention: Nomogram model developed using independent prognostic factors (Grade, T stage, liver surgery, chemotherapy, radiation recode, alpha‐fetoprotein level, fibrosis score, tumor size group, M stage)
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 1346
Study: 32280089

Group type: EXPERIMENTAL
Intervention: Hydromethylthionine 200 mg/day
Number of subjects: 220

Group type: COMPARATOR
Intervention: Hydromethylthionine 8 mg/day (control)
Number of subjects: 220
Study: 33778921

Group type: EXPERIMENTAL
Intervention: Consultation time and written results (Class 1)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Cost (Class 2)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Consultation time, waiting time, and lifestyle recommendations (Class 3)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Cost
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Predicted uptake rates for health checks
Number of subjects: 432
Study: 33246408

Group type: EXPERIMENTAL
Intervention: Cognitive tests (SDMT, MMSE)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Physical performance tests (Astrand, TUG, STS, Stroop)
Number of subjects: 185
Study: 33871159

Group type: EXPERIMENTAL
Intervention: Various trials (not specified)
Number of subjects: 2500
Study: 33001556

Group type: EXPERIMENTAL
Intervention: DPP‐4 inhibitor sitagliptin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35984773

Group type: EXPERIMENTAL
Intervention: Endobiliary stent placement
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Risk scoring scheme for predicting TB normalization
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Risk scoring scheme for predicting absence of TB normalization
Number of subjects: 511
Study: 32658822

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 35385032

Group type: EXPERIMENTAL
Intervention: Thrombectomy alone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bridging therapy (intravenous alteplase at a standard dose of 0.9 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 34102077

Group type: EXPERIMENTAL
Intervention: Insomnia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short and long sleep durations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Favorable sleep as part of a healthy lifestyle
Number of subjects: 0
Study: 32536527

Group type: EXPERIMENTAL
Intervention: Remnant-preserving anatomic reconstruction of the ATFL using ipsilateral free semitendinosus tendon autograft
Number of subjects: 53

Group type: COMPARATOR
Intervention: Non-preserving anatomic reconstruction of the ATFL using ipsilateral free semitendinosus tendon autograft
Number of subjects: 53
Study: 33310204

Group type: EXPERIMENTAL
Intervention: Higher plasma levels of growth differentiation factor 15 (GDF-15)
Number of subjects: 2552

Group type: EXPERIMENTAL
Intervention: Higher plasma levels of interleukin 6 (IL-6)
Number of subjects: 2552
Study: 34352135

Group type: EXPERIMENTAL
Intervention: Repeated video-training sessions
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no video-training)
Number of subjects: 40
Study: 32462947

Group type: EXPERIMENTAL
Intervention: ctDCS stimulation over the left M1
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: ctDCS stimulation over the PPC
Number of subjects: 28
Study: 32653025

Group type: EXPERIMENTAL
Intervention: KAIA COPD app program
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual care (active comparator)
Number of subjects: 104
Study: 36114799

Group type: EXPERIMENTAL
Intervention: Valbenazine 40-mg
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Valbenazine 80-mg
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Valbenazine (after switching from placebo at Week 6)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Valbenazine 40-mg and 80-mg
Number of subjects: 256
Study: 33653802

Group type: EXPERIMENTAL
Intervention: Rapamycin 0.5 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Rapamycin 2.0 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 36145067

Group type: EXPERIMENTAL
Intervention: LCHF diet (<50 g CHO p/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: HCLF diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: LCHF diet
Number of subjects: 16
Study: 34560444

Group type: EXPERIMENTAL
Intervention: Blood pressure measurement per routine intraoperatively, and with continuous non‐invasive monitoring postoperatively
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Intraoperative hypotension
Number of subjects: 550
Study: 615901264

Group type: EXPERIMENTAL
Intervention: Testosterone gel (1.25 g, 2.5 g, 5.0 g, 10 g, or 15 g)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Double placebo (injections and gel)
Number of subjects: 48
Study: 34238815

Group type: EXPERIMENTAL
Intervention: IDEAL 2b study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other methods (observational study designs, registry-based approaches)
Number of subjects: 0
Study: 32342885

Group type: EXPERIMENTAL
Intervention: Explosives detection systems for cabin baggage screening (EDSCB) with varying automation reliability measures (accuracy, d', PPV)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Explosives detection systems for cabin baggage screening (EDSCB) with higher d'
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Explosives detection systems for cabin baggage screening (EDSCB) with a high false alarm rate of 20% and a low PPV of .3
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Automation reliability described by d' and PPV
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Automation with PPV below .5
Number of subjects: 122
Study: 36484186

Group type: EXPERIMENTAL
Intervention: Tiaohe Yinyang acupotomy
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sham‐acupotomy
Number of subjects: 88
Study: 34385364

Group type: EXPERIMENTAL
Intervention: FIL200 + MTX
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: FIL100 + MTX
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: FIL200
Number of subjects: 510

Group type: COMPARATOR
Intervention: MTX-mono
Number of subjects: 510
Study: 32595022

Group type: EXPERIMENTAL
Intervention: Frozen-section examination (FSE) of sentinel lymph nodes (SLN)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Ultrastaging of negative SLNs by FSE
Number of subjects: 313

Group type: COMPARATOR
Intervention: Tumor size ≥ 20 mm
Number of subjects: 313

Group type: COMPARATOR
Intervention: Preoperative brachytherapy
Number of subjects: 313

Group type: COMPARATOR
Intervention: Higher volume center (>5 patients/year)
Number of subjects: 313
Study: 34597384

Group type: EXPERIMENTAL
Intervention: Vitamin C (antioxidant)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 58
Study: 33723119

Group type: EXPERIMENTAL
Intervention: Hall Technique (HT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional Restoration (CR)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both HT and CR
Number of subjects: 35
Study: 32335270

Group type: EXPERIMENTAL
Intervention: Intragastric ethanol infusion (IGEI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous ethanol infusion (IVEI)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both IGEI and IVEI
Number of subjects: 12
Study: 35025163

Group type: EXPERIMENTAL
Intervention: Heat-sensitive moxibustion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36309846

Group type: EXPERIMENTAL
Intervention: Supplemental vitamin A (10,000 IU/day orally for 3 to 4 weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: No supplemental vitamin A (control)
Number of subjects: 47
Study: 33561277

Group type: EXPERIMENTAL
Intervention: Scalp Acupuncture (SA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Occlusal Splint (OS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Counseling (C)
Number of subjects: 60
Study: 32207158

Group type: EXPERIMENTAL
Intervention: Portion-control intervention (PCI) group received weekly, telephone-delivered behavioral counseling over 12 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Newsletter group received monthly newsletters regarding healthy eating.
Number of subjects: 0
Study: 35316099

Group type: EXPERIMENTAL
Intervention: Self-adjusted hearing aid amplification
Number of subjects: 15

Group type: COMPARATOR
Intervention: NAL-NL2 prescriptive fit
Number of subjects: 15

Group type: COMPARATOR
Intervention: Experimenter-created fits with reduced gain
Number of subjects: 15
Study: 34828764

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no local anesthetic)
Number of subjects: 60
Study: 32940653

Group type: EXPERIMENTAL
Intervention: Timolol thermosensitive gel (0.1%) applied twice daily for 8 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo thermosensitive gel applied twice daily for 8 weeks
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Timolol thermosensitive gel (0.1%)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo thermosensitive gel
Number of subjects: 27
Study: 33879185

Group type: EXPERIMENTAL
Intervention: Comorbidity burden
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Self-rated health (not good vs. good)
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Mental health wellbeing
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Number of offspring (among Jewish participants)
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Perceived difficulty (among Jewish participants)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Sociodemographics, health behaviors, knowledge and attitudes/beliefs
Number of subjects: 520
Study: 35766991

Group type: EXPERIMENTAL
Intervention: One-on-one 30- to 45-min psychosocial counseling session with a psychosexual counselor plus written educational materials
Number of subjects: 31

Group type: COMPARATOR
Intervention: Written materials alone
Number of subjects: 31
Study: 32363940

Group type: EXPERIMENTAL
Intervention: IMMAX® + nutritional counseling (NC) for 4 weeks
Number of subjects: 85

Group type: COMPARATOR
Intervention: Nutritional counseling (NC) alone for 4 weeks
Number of subjects: 85
Study: 32663518

Group type: EXPERIMENTAL
Intervention: In vivo confocal microscopy (IVCM) for NCP patients
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: In vivo confocal microscopy (IVCM) for DED patients
Number of subjects: 71

Group type: COMPARATOR
Intervention: In vivo confocal microscopy (IVCM) for NCP and DED patients
Number of subjects: 71
Study: 35303782

Group type: EXPERIMENTAL
Intervention: Ribociclib plus endocrine therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ribociclib and fulvestrant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ribociclib
Number of subjects: 0
Study: 32398199

Group type: EXPERIMENTAL
Intervention: Double-dose rifampicin (20 mg/kg/d)
Number of subjects: 690

Group type: COMPARATOR
Intervention: Standard dose rifampicin (10 mg/kg/d)
Number of subjects: 690
Study: 36055669

Group type: EXPERIMENTAL
Intervention: Topical TXA 2 g
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: IV TXA 2 g
Number of subjects: 452

Group type: COMPARATOR
Intervention: NO TXA (Control)
Number of subjects: 452